3 × 14 mg/m2 Idarubicin during induction: results of a pilot study in children with AML

Publisher Website

25 January 2000

journal article
Published by Springer Nature in Leukemia

Vol. 14 (2) , 340-342
https://doi.org/10.1038/sj.leu.2401670

Abstract

No abstract available

Keywords

This publication has 2 references indexed in Scilit:

Definition of a standard‐risk group in children with AML
British Journal of Haematology, 1999
Cytarabine plus idarubicin or daunorubicin as induction and consolidation therapy for previously untreated adult patients with acute myeloid leukemia
Blood, 1992